← Leaderboards
Timothy M Block
Callisto Pharmaceuticals, Inc.
$22,933,691
Attributed
$22,933,691
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$22,933,691 · 11
By mechanism
U01$15,669,652 · 4
R01$6,585,631 · 2
P50$401,536 · 1
R21$155,205 · 1
R41$97,917 · 1
R13$23,750 · 2
Top collaborators
No co-investigators on record.
Most similar at Callisto Pharmaceuticals, Inc.
Same institution · by research overlap
- Anand S Mehta$15,171,193
Others in their field
Top investigators on “Antiviral Agents”
- Constance Ann Benson · University Of California, San Diego$209,152,068
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$120,325,769
- Judith S. Currier · University Of California Los Angeles$102,391,456
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- Sharon A Nachman · Johns Hopkins University$77,262,665
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,660,403
Research focus
Antiviral AgentsBaseEarly DiagnosisBlood CirculationModificationSugarBiomarkerHepatitis BGlycoproteinsLiver DiseasesPrimary Carcinoma Of The Liver CellsCooperative StudyHepatitis C VirusMalignant Neoplasm Of LiverProteinsDiagnosisHuman Cell LinePathway InteractionsTissuesValidationAnimal ModelVirusOralVirus Diseases
Grant awards (48)
A small molecule for management of filovirus hemorrhagic fevers$980,944
R01 · FY2017 · AI · contact PI
2017 International Meeting on the Molecular Biology of Hepatitis B Viruses$6,250
R13 · FY2017 · AI · contact PI
A small molecule for management of filovirus hemorrhagic fevers$879,526
R01 · FY2016 · AI · contact PI
A small molecule for management of filovirus hemorrhagic fevers$950,337
R01 · FY2015 · AI · contact PI
A small molecule for management of filovirus hemorrhagic fevers$837,767
R01 · FY2014 · AI · contact PI
A small molecule for management of filovirus hemorrhagic fevers$77,165
R01 · FY2014 · AI · contact PI
A small molecule for management of filovirus hemorrhagic fevers$873,245
R01 · FY2013 · AI · contact PI
Liver Cancer and the Role of Protein Hyper-Fucosylation$297,559
R01 · FY2013 · CA · contact PI
Liver Cancer and the Role of Protein Hyper-Fucosylation$6,239
R01 · FY2013 · CA · contact PI
Liver Cancer and the Role of Protein Hyper-Fucosylation$364,642
R01 · FY2012 · CA · contact PI
Liver Cancer and the Role of Protein Hyper-Fucosylation$325,963
R01 · FY2011 · CA · contact PI
Liver Cancer and the Role of Protein Hyper-Fucosylation$377,707
R01 · FY2010 · CA · contact PI
Imino sugars for flavivirus infections of bioterror$345,938
U01 · FY2010 · AI · contact PI
Early Detection of Liver Cancer$154,000
U01 · FY2010 · CA · contact PI
Imino sugars for flavivirus infections of bioterror$1,717,119
U01 · FY2009 · AI · contact PI
Early Detection of Liver Cancer$311,079
U01 · FY2009 · CA · contact PI
Liver Cancer and the Role of Protein Hyper-Fucosylation$309,775
R01 · FY2009 · CA · contact PI
Liver Cancer and the Role of Protein Hyper-Fucosylation$304,762
R01 · FY2009 · CA · contact PI
Early Detection of Liver Cancer$167,925
U01 · FY2009 · CA · contact PI
Imino sugars for flavivirus infections of bioterror$96,787
U01 · FY2009 · AI · contact PI
Imino sugars for flavivirus infections of bioterror$1,676,924
U01 · FY2008 · AI · contact PI
Early Detection of Liver Cancer$424,009
U01 · FY2008 · CA · contact PI
Early Detection of Liver Cancer$150,000
U01 · FY2008 · CA · contact PI
Imino sugars for flavivirus infections of bioterror$1,496,845
U01 · FY2007 · AI · contact PI
Early Detection of Liver Cancer$469,378
U01 · FY2007 · CA · contact PI
Imino sugars for flavivirus infections of bioterror$1,209,216
U01 · FY2006 · AI · contact PI
Early Detection of Liver Cancer$442,492
U01 · FY2006 · CA · contact PI
Therapeutic HBV vaccines with glucosidase inhibitors$422,662
U01 · FY2006 · AI · contact PI
Imino sugars for flavivirus infections of bioterror$1,253,863
U01 · FY2005 · AI
Therapeutic HBV vaccines with glucosidase inhibitors$642,185
U01 · FY2005 · AI
Early Detection of Liver Cancer$451,837
U01 · FY2005 · CA
International Conference on Hepatitis B Viruses$17,500
R13 · FY2005 · AI
Therapeutic HBV vaccines with glucosidase inhibitors$625,949
U01 · FY2004 · AI
Early Detection of Liver Cancer$439,850
U01 · FY2004 · CA
Therapeutic HBV vaccines with glucosidase inhibitors$81,085
U01 · FY2004 · AI
Therapeutic HBV vaccines with glucosidase inhibitors$656,839
U01 · FY2003 · AI
EARLY DETECTION OF LIVER CANCER AND HEPATITIS$378,440
U01 · FY2003 · CA
Antiviral agents for Flavivirus infections of bioterror$319,836
U01 · FY2003 · AI
Antiviral agents for Flavivirus infections of bioterror$145,377
U01 · FY2003 · AI
Therapeutic HBV vaccines with glucosidase inhibitors$437,672
U01 · FY2002 · AI
EARLY DETECTION OF LIVER CANCER AND HEPATITIS$367,703
U01 · FY2002 · CA
HERPES SIMPLEX VIRUS AND NGF DIFFERENTIATED PC12 CELL INTERACTION$200,768
P50 · FY2002 · NS
Viral antigen glycosylation--Marker for HBV induced HCC?$155,205
R21 · FY2002 · CA
EARLY DETECTION OF LIVER CANCER AND HEPATITIS$354,119
U01 · FY2001 · CA
HERPES SIMPLEX VIRUS AND NGF DIFFERENTIATED PC12 CELL INTERACTION$200,768
P50 · FY2001 · NS
EARLY DETECTION OF LIVER CANCER AND HEPATITIS$74,625
U01 · FY2001 · CA
EARLY DETECTION OF LIVER CANCER AND HEPATITIS$355,898
U01 · FY2000 · CA
MUTATION 'REFRACTION'BROAD SPECTRUM ANTI-HEPATITIS DRUG$97,917
R41 · FY2000 · GM